Essayer OR - Gratuit
Blood Test For Detecting Cancer
DataQuest
|November 2019
53% of companies openly admit that limited IT resources are significantly slowing down their digital transformation efforts. Here is how an organization tackles this issue
The final and inconclusive proof of the disease is tissue biopsy, a relatively painful process. In certain cases, the tumour is not accessible or the patient is very weak for biopsy. How then do the can oncologists confirm the presence of cancer?
Cancer is a dreaded term in most families. Across the globe, annually about 8 million people die of cancer. In USA alone, every year about 40,000 women die of breast cancer. Mammograms are the best test, yet they often produce false positives, which can warrant unwanted biopsies and surgeries. So called, “high-risk” lesions have abnormal cells and patients are advised surgery. About 90% of the time, the lesion is benign and surgery is an expensive and painful wasted exercise. The final and inconclusive proof of the disease is tissue biopsy, a relatively painful process. In certain cases, the tumour is not accessible or the patient is very weak for biopsy. How then do can oncologists confirm the presence of cancer?
The Research
The research related to cancer is predominantly on two major fronts – 1) to find drugs and ways to treat cancer and 2) to detect cancer at a very early stage where the chances of recovery and remission are high. Typically, people suspect cancer as the cause only when it manifests in some obvious and visible form. Nevertheless, often by then, the disease has progressed to an advanced stage – a stage beyond treatment. Can doctors detect them very early even before the person feels any symptoms? By detecting early, doctors can treat and save many lives and spare many people of anxiety and agony.
Can a simple blood test predict, detect and confirm the presence of cancer? yes, for a few types of cancers it is possible. Colorectal Cancer (CRC) is one for which a blood test is available. Testing the blood for the presence of tumour cells and DNA is a non-invasive approach compared to the invasive biopsy, which is a surgery.
Cette histoire est tirée de l'édition November 2019 de DataQuest.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE DataQuest
DataQuest
Engineering India's Al-First Data Centres at Hyperscale
Rohan Sheth explains how AI and HPC are reshaping India's data centres, from density and cooling to power economics, sustainability, and hyperscale decision criteria.
4 mins
February 2026
DataQuest
From copilots to colleagues: Why agentic AI is forcing enterprises to rethink control, trust, and culture
As AI agents shift from assisting to acting, enterprises must redesign governance, data controls, and security guardrails so autonomy stays auditable, reversible, and trusted.
2 mins
February 2026
DataQuest
Reclaiming Control in the AI Era: A Conversation with Kalyan Kumar, CPO, HCLSoftware
Enterprises are reassessing cloud-first strategies as AI becomes core to operations. HCLSoftware's Kalyan Kumar explains why sovereignty, choice and control now shape decisions.
5 mins
February 2026
DataQuest
When infrastructure learns: The rise of the Al-native core
AI-native infrastructure is moving from concept to operational reality, reshaping how organisations build, govern, and scale intelligence across their digital core.
6 mins
February 2026
DataQuest
Bridging the gap between connectivity and compute at scale
As AI scales in India, data centres are evolving into high-density, low-latency platforms that unify connectivity, compute, and sustainability at national scale.
4 mins
February 2026
DataQuest
PUE is not a grapefruit metric, anymore
So what are the new high-hanging fruits for data centre strategists today? And are players going after them?
4 mins
February 2026
DataQuest
Even if Al demand fades, India need not worry - about data centres
For every megawatt (MW) of installed colocation capacity, users here generate approximately 13.2 PB of data monthly- compared to 0.3 PB for Australia and just 0.01 PB for Singapore. India's data centre growth is not dependent on one tech lever. Plus, it is phased and modular and not kneejerk. Manoj Paul explains these contours in detail.
7 mins
February 2026
DataQuest
AI infrastructure and systemic risk
What has been the biggest change in data centre industry-specially after AI workloads? Is Al-bubble a big risk for data centre infra- how much will it affect data centres if something cracks?
1 min
February 2026
DataQuest
Inside the Shift to High-Density, Al-Ready Data Centres
CtrlS' Vipin Jain discusses what it truly takes to build AI-ready data centres in India, balancing high density, liquid-ready cooling, resilience, and ESG accountability.
4 mins
February 2026
DataQuest
Sustainability is now the headline, not a footnote
Sanjay Agrawal, Head Presales and CTO at Hitachi Vantara India and SAARC opines that the conversation is moving beyond headline metrics like PUE toward a broader view of how data lifecycle management and infrastructure efficiency reduce the overall environmental footprint. Let's see why and how- while also touching upon adjacent (or not-so-adjacent) factors like redundancies, availability and AI-readiness
3 mins
February 2026
Translate
Change font size
